treatment of physician's choice trials for Breast cancer

All treatment of physician's choice trials · All Breast cancer trials

Phase breakdown

Recruiting trials studying treatment of physician's choice for Breast cancer

• Artificial Intelligence and Machine Learning to Guide CDK4/6 Inhibitor Rechallenge in Breast Cancer.
  NCT07227233 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Chemotherapy Omission in ER+/HER2- Breast Cancer With 1-3 Positive Lymph Nodes Receiving Extended Adjuvant Abemaciclib
  NCT06341621 · Phase: Phase 3 · Ages: 18 Years to 80 Years · Sex: Female · 1 location
• Pyrotinib Plus Capecitabine for Adjuvant Treatment of HER2 Positive Early-stage Breast Cancer
  NCT06035016 · Phase: Not specified · Ages: 18 Years to 75 Years · Sex: Female · 1 location
• Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
  NCT06072612 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 79 locations

Common questions

How many trials study treatment of physician's choice for Breast cancer?

4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.